PRESS RELEASE published on 11/04/2025 at 15:52, 5 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses a 10.61% stake in Qualcomm Incorporated as of 03 Nov 2025. Also making disclosures related to Alphawave IP Group plc Disclosure Vanguard Group Stake Qualcomm Alphawave IP Group
BRIEF published on 11/04/2025 at 15:51, 5 months 17 days ago The Vanguard Group Discloses Position in Mural Oncology plc Form 8.3 Irish Takeover Panel The Vanguard Group Shareholding Disclosure Mural Oncology Plc
PRESS RELEASE published on 11/04/2025 at 15:51, 5 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses 7.47% ownership in American Axle & Manufacturing Holdings, Inc. Form 8.3 submitted on 04-Nov-2025 Form 8.3 Vanguard Group Ownership Disclosure Financial Disclosure American Axle
BRIEF published on 11/04/2025 at 15:50, 5 months 17 days ago The Vanguard Group's Interest in Greencore Group plc The Vanguard Group Stake Disclosure Stock Transactions Investment Transparency Greencore Group Plc
PRESS RELEASE published on 11/04/2025 at 15:49, 5 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.05% stake in JTC plc. Position disclosure under Rule 8.3 of the Takeover Code Disclosure Takeover Code Vanguard Group Stake JTC Plc
PRESS RELEASE published on 11/04/2025 at 15:48, 5 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.67% interest in Avadel Pharmaceuticals plc on 03 November 2025 The Vanguard Group, Inc. Irish Takeover Panel Interest Disclosure Stock Holdings Avadel Pharmaceuticals Plc
BRIEF published on 11/04/2025 at 15:48, 5 months 17 days ago Vanguard Discloses Position in Spire Healthcare Securities Form 8.3 Takeover Code Spire Healthcare Vanguard
PRESS RELEASE published on 11/04/2025 at 15:46, 5 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses 1.67% ownership in Mural Oncology plc. No other party disclosures made. Details on Form 8.3 The Vanguard Group, Inc. Form 8.3 Ownership Disclosure Financial Disclosure Mural Oncology Plc
BRIEF published on 11/04/2025 at 15:46, 5 months 17 days ago The Vanguard Group Discloses Position in Alphawave IP Group Form 8.3 Takeover Code Vanguard Group Stock Disclosure Alphawave IP
PRESS RELEASE published on 11/04/2025 at 15:45, 5 months 17 days ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses a 5.36% stake in Greencore Group plc through Form 8.3 filing. Also making disclosures related to Bakkavor Group plc Form 8.3 Vanguard Group Disclosures Greencore Group Plc Bakkavor Group Plc
Published on 04/22/2026 at 01:55, 9 hours 38 minutes ago Immutable Holdings Announces Director Resignation
Published on 04/22/2026 at 01:30, 10 hours 3 minutes ago Challenger West Assays Return Grades up to 60g/t Au
Published on 04/22/2026 at 00:00, 11 hours 33 minutes ago Zimtu Capital Corp. and Global Energy Metals Corporation Agree to Terminate Option Agreement for the Monument Peak Copper-Silver Project, Idaho
Published on 04/22/2026 at 00:00, 11 hours 33 minutes ago Grande Portage Resources Announces SEDAR+ Filing of Preliminary Economic Assessment (PEA) Study for the New Amalga Gold Project in SE Alaska
Published on 04/22/2026 at 10:32, 1 hour 1 minute ago EQS-Adhoc: K+S Aktiengesellschaft: EBITDA and adjusted free cash flow in the first quarter of 2026 significantly above market expectations; EBITDA forecast for the full year 2026 raised
Published on 04/22/2026 at 10:18, 1 hour 15 minutes ago Successful Listing on the Primary Market of Düsseldorf Stock Exchange Strengthens Capital Market Position and Growth Strategy
Published on 04/22/2026 at 10:00, 1 hour 33 minutes ago Vossloh to supply railway project in Tanzania
Published on 04/22/2026 at 09:35, 1 hour 58 minutes ago Iconic British Brand Laura Ashley launches Four Fragrances Inspired by Archival Prints
Published on 04/22/2026 at 09:19, 2 hours 14 minutes ago EQS-Adhoc: TUI expects to report underlying EBIT for Q2 FY 2026 ahead of prior year, but adjusts FY 2026 underlying EBIT guidance at constant currency due to the continuing Iran war
Published on 04/22/2026 at 07:00, 4 hours 33 minutes ago Q1 2026 sales. €229.5m at constant exchange rates. €215.5m at current exchanges rates
Published on 04/21/2026 at 19:15, 16 hours 18 minutes ago AXA - Description of the Company’s share repurchase program
Published on 04/21/2026 at 18:00, 17 hours 33 minutes ago Outstanding shares and voting rights statement at 31 March 2026
